134 related articles for article (PubMed ID: 36416121)
21. Simultaneous Estimation of Escitalopram and Clonazepam in Tablet Dosage Forms Using HPLC-DAD Method and Optimization of Chromatographic Conditions by Box-Behnken Design.
Foudah AI; Alshehri S; Shakeel F; Alqarni MH; Aljarba TM; Alam P
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807458
[TBL] [Abstract][Full Text] [Related]
22. Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms.
Chakravarthy VA; Sailaja BB; Kumar AP
J Anal Methods Chem; 2015; 2015():735145. PubMed ID: 25705547
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances.
Gu P; Li Y
J Chromatogr Sci; 2009 Aug; 47(7):594-8. PubMed ID: 19772734
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a stability-indicating, single HPLC method for sacubitril-valsartan and their stereoisomers and identification of forced degradation products using LC-MS/MS.
Vijaykumar C; Kumar YR; Aparna P; Rao PSP
Biomed Chromatogr; 2023 Feb; 37(2):e5550. PubMed ID: 36410774
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma.
Mehmood Y; Khan IU; Shahzad Y; Khalid SH; Irfan M; Asghar S; Yousaf AM; Hussain T; Khalid I
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1835-1842. PubMed ID: 31680080
[TBL] [Abstract][Full Text] [Related]
26. Validated stability-indicating RP-HPLC method for the determination of rimonabant in a pharmaceutical dosage form.
Hurtado FK; Ravanello A; Arend MZ; Wrasse M; Dalmora SL; Rolim CM
J AOAC Int; 2010; 93(3):869-75. PubMed ID: 20629389
[TBL] [Abstract][Full Text] [Related]
27. Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of Impurity-VII, VIII and IX and Synthesis of Impurity-VII.
Jadhav SB; Reddy PS; Narayanan KL; Bhosale PN
Sci Pharm; 2017 Jun; 85(3):. PubMed ID: 28653975
[TBL] [Abstract][Full Text] [Related]
28. A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.
Suleman S; Vandercruyssen K; Wynendaele E; D'Hondt M; Bracke N; Duchateau L; Burvenich C; Peremans K; De Spiegeleer B
Malar J; 2013 Apr; 12():145. PubMed ID: 23631682
[TBL] [Abstract][Full Text] [Related]
29. [Impurity profile of macitentan in tablet dosage form using a stability-indicating high performance liquid chromatography method and forced degradation study].
Lakka NS; Kuppan C; Rangasamy P
Se Pu; 2019 Jan; 37(1):100-110. PubMed ID: 30693716
[TBL] [Abstract][Full Text] [Related]
30. A rapid RP-HPLC stability-indicating method development and validation of moxifloxacin hydrochloride-related substances in finished dosage forms.
Vankalapati KR; Algete P; Boodida S
Biomed Chromatogr; 2021 Nov; 35(11):e5192. PubMed ID: 34110029
[TBL] [Abstract][Full Text] [Related]
31. Reversed-phase ultra-performance liquid chromatographic method development and validation for determination of impurities related to torsemide tablets.
Patel HB; Mohan A; Joshi HS
J AOAC Int; 2011; 94(1):143-9. PubMed ID: 21391491
[TBL] [Abstract][Full Text] [Related]
32. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
33. Assay of afoxolaner and determination of its related substances in commercial bulk batches of afoxolaner by reversed-phase HPLC method based on a short octadecyl column.
Padivitage N; Adhikari S; Rustum AM
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1184():122984. PubMed ID: 34644667
[TBL] [Abstract][Full Text] [Related]
34. Validated stability-indicating HPLC-UV method for simultaneous determination of glipizide and four impurities.
Gupta S; Bansal G
J AOAC Int; 2011; 94(2):523-30. PubMed ID: 21563686
[TBL] [Abstract][Full Text] [Related]
35. Development of a stability- indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance.
Luo Z; Liu A; Liu Y; Wang G; Chen X; Wang H; Li M; Zhang H; Qiu Y; Zhai H
J Pharm Biomed Anal; 2018 Feb; 149():133-142. PubMed ID: 29112902
[TBL] [Abstract][Full Text] [Related]
36. Fast RP-HPLC Method for the Determination of Bisoprolol.
Panainte AD; Vieriu M; Ţântaru G; Apostu M; Bibire N
Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):720-6. PubMed ID: 30152661
[TBL] [Abstract][Full Text] [Related]
37. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2021 Sep; 59(9):830-846. PubMed ID: 33420506
[TBL] [Abstract][Full Text] [Related]
38. Development of an effective novel validated stability-indicating HPLC method for the resolution of brivaracetam stereoisomeric impurities.
Baksam V; N S; Pocha VR; Chakka VB; Ummadi RR; Kumar P
Chirality; 2020 Sep; 32(9):1208-1219. PubMed ID: 32656914
[TBL] [Abstract][Full Text] [Related]
39. Stability-Indicating RP-HPLC Method for the Estimation of Process-Related Impurities and Degradation Products in Fesoterodine Fumarate by Using a Mass Spectrometric Compatible Mobile Phase.
Kumar N; Sangeetha D; Kalyanraman L
J Chromatogr Sci; 2021 Jan; 59(2):154-164. PubMed ID: 33190158
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products.
Ragham PK; Chandrasekhar KB
J Pharm Biomed Anal; 2016 Jun; 125():122-9. PubMed ID: 27018505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
